IXICO's AGM Results

January 29, 2016
News

Download AGM Results

IXICO plc (Ticker: IXI) (“IXICO” or the “Company”), the brain health company, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed. 


Enquiries
 
IXICO plc    
Derek Hill, CEO    
Susan Lowther, CFO    

+44 20 3763 7499
    
Peel Hunt LLP (Nominated Adviser and Broker)    
James Steel / Oliver Jackson    

+44 20 7418 8900
    
Daniel Stewart & Company (Joint Broker)    
Martin Lampshire / David Coffman    

+44 207 776 6550
    
FTI Consulting Limited (Investor Relations)    
Simon Conway / Mo Noonan / Matthew Moss    

+44 20 3727 1000


Notes to Editors

About IXICO
IXICO’s innovative and proprietary digital healthcare technologies help those involved in researching and treating serious diseases to capture and analyse clinical data to make rapid, informed decisions.  In clinical research this includes the phenotyping of patients, quantification of disease pathology and measurement of patient outcomes.  In clinical practice the mobile health and digital decision support technologies aid diagnosis, patient engagement and monitoring. IXICO is also collaborating with partners to develop companion digital health products targeted at improving patient outcomes.

The Company’s brain health focus includes Alzheimer’s disease, Huntington’s disease, Multiple Sclerosis, behavioural health, child and adolescent mental health.

More information is available on www.ixico.com